MARKET WIRE NEWS

Generics Stalwart Teva Has Turned A Corner In Its Specialty Medicines Business

Source: SeekingAlpha

2025-11-14 10:38:47 ET

Thesis

Teva Pharmaceutical Industries Limited ( TEVA ), founded in 1901 and based in Israel, has developed into one of the world’s leading generics drug companies. They rank closely with Sandoz ( SDZNY ), Viatris ( VTRS ) – formed in 2020 as a merger between Upjohn and Mylan – Sun Pharma, and Dr. Reddy’s ( RDY ), all of which have developed over several decades the capacity to leverage their size and manufacturing capabilities to claim a decent share of the market. These companies operate a kind of oligopoly in this niche space....

Read the full article on Seeking Alpha

For further details see:

Generics Stalwart Teva Has Turned A Corner In Its Specialty Medicines Business
Takeda Pharmaceutical Co Ltd

NASDAQ: TKPHF

TKPHF Trading

0.0% G/L:

$37.83 Last:

113 Volume:

$37.83 Open:

mwn-link-x Ad 300

TKPHF Latest News

TKPHF Stock Data

$55,801,616,447
1,559,387,460
N/A
724
N/A
Pharmaceuticals
Healthcare
JP
Chuo-ku

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App